Pfizer Inc.’s (PFE.N) antiviral treatment Paxlovid reduces COVID-19 hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coronavirus.
Posts
Omicron breakthrough infections may spare young hearts; no need to delay mammogram after vaccination
Antibodies, BioNTech, BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, Cardiovascular, COVID-19 booster shots, COVID-19 shots, COVID-19 Studies, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Heart, Immune Cells, Immune Response, Lancet Infectious Diseases, Mammography, Messenger RNA (mRNA) Vaccines, Omicron (B.1.1.529) (South Africa), Pfizer, R&D, T-Cells, WomenThe Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.